Skip to content
by Legal Desire
24 October 2023

Latham & Watkins Advises Arcutis Biotherapeutics on Pricing of US$100 Million Public Offering

Advising firms

Deal team

13 lawyers named
LawyerFirmSeniorityPracticeOffice
Ross McAloon Lead Latham & Watkins LLP Partner capital markets Not stated
Shayne Kennedy Lead Latham & Watkins LLP Partner capital markets Not stated
Mekbeb Hagos Latham & Watkins LLP Associate capital markets Orange County
David Stepovich Latham & Watkins LLP Associate capital markets Orange County
Grace Lee Latham & Watkins LLP Partner tax Bay Area
Gregory Conyers Latham & Watkins LLP Associate tax Not stated
Rasha Suleiman Latham & Watkins LLP Associate tax Not stated
Elizabeth Richards Latham & Watkins LLP Partner healthcare and life sciences Washington, D.C.
Heather Deixler Latham & Watkins LLP Partner healthcare and life sciences Bay Area
Betty Pang Latham & Watkins LLP Partner healthcare and life sciences Bay Area
Chad Jennings Latham & Watkins LLP Counsel healthcare and life sciences Washington, D.C.
Kiera Murphy Latham & Watkins LLP Associate healthcare and life sciences San Diego
Mitch Bennett Latham & Watkins LLP Associate healthcare and life sciences Bay Area

10 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 100m (US$100.0 million)
What the figure measures
Issue size
Client
Arcutis BiotherapeuticsIssuer
Counterparties
Not stated